Copyrights and Licensing2

In open access publishing, authors maintain the copyright of their published articles.

If you reuse our articles contents, please read the following licensing policy carefully before contacting us.

1. Articles published 2026 onward are licensed under CC-BY 4.0.

Articles published 2026 onward are distributed under the terms of Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, including commercial use, provided the original work is properly cited.

Under license CC-BY, your may reuse and reproduce these articles contents for commercial or non-commercial purposes without contacting us.

2. Articles published prior to 2026 are licensed under CC-BY-NC (Attribution–Non-Commercial) license

Articles published prior to 2026 are distributed under the terms of Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

For articles published prior to 2026, please contact production@elmerpress.com for permission and quotation if you reuse our articles for commercial purposes, or if you have any questions.

What is commercial or non-commercial reuse

Non-Commercial Use may Include but not limited to the Following

Share the complete text or a summary of their own article on their personal or institutional websites.

Creating a reasonable quantity of copies for personal or non-commercial professional purposes, such as facilitating the authors' own teaching responsibilities.

Incorporating the article within an educational course pack or compilation, whether in physical or digital form, within the authors' institution.This provision is void if the compilation or training program involves a commercial fee.

Commercial Use may include but not limited to the Following

Introducing paid advertising when distributing or presenting the published article through online or print formats.

Employing the published articles for purposes of redistribution, sale, licensing, or other commercial ventures in exchange for a fee.

Including segments or complete published articles within other creations in exchange for a fee.

Utilizing portions or entirety of the published articles by organizations or entities for promotional or advertising intentions, subject to a fee.

Any distribution, whether partial or complete, of published articles by pharmaceutical agencies is universally categorized as commercial use.

Reprinting portions or the entirety of the article within a book or other publication, whether edited by the author or others, where the book is intended for sale and profit.

For articles published prior to 2026, please contact production@elmerpress.com for permission and quotation if you reuse our articles for commercial purposes, or if you have any questions.

Please note that Elmer Press Inc does not authorize any copyright or licensing agencies to represent us for the collection of licensing fees or reproduction royalties. Any misrepresentation claiming authority to collect such fees on our behalf may result in legal action.